Another possible explanation for the co-occurrence of LGL leukemia and RA is that LGL leukemia develops as a result of the immunomodulating therapies used to treat RA, namely treatment with tumor necrosis factor (TNF) inhibitors. The gene discussed is TNF; the disease is T-cell large granular lymphocyte leukemia.